Below are the most recent publications written about "Cyclin-Dependent Kinase Inhibitor p16" by people in Profiles.
-
Monda SM, Carney BW, May AM, Gulati S, Salami SS, Chandrasekar T, Keller ET, Huebner NA, Palapattu GS, Dall'Era MA. Differences?in mutations across tumour sizes in clear-cell renal cell carcinoma. BJU Int. 2025 Feb; 135(2):269-278.
-
Wasserman JS, Fowle H, Hashmi R, Atar D, Patel KR, Yarmahmoodi A, Macfarlane AW, Tan Y, Cukierman E, Gligorijevic B, Karami A, Whelan KA, Campbell KS, Gra?a X. Derivation of human primary prostate epithelial cell lines by differentially targeting the CDKN2A locus along with expression of hTERT. Sci Rep. 2024 09 02; 14(1):20409.
-
Tillmanns N, Lost J, Tabor J, Vasandani S, Vetsa S, Marianayagam N, Yalcin K, Erson-Omay EZ, von Reppert M, Jekel L, Merkaj S, Ramakrishnan D, Avesta A, de Oliveira Santo ID, Jin L, Huttner A, Bousabarah K, Ikuta I, Lin M, Aneja S, Turowski B, Aboian M, Moliterno J. Application of novel PACS-based informatics platform to identify imaging based predictors of CDKN2A allelic status in glioblastomas. Sci Rep. 2023 12 22; 13(1):22942.
-
Pellegrini C, Cardelli L, Ghiorzo P, Pastorino L, Potrony M, Garc?a-Casado Z, Elefanti L, Stefanaki I, Mastrangelo M, Necozione S, Aguilera P, Rodr?guez-Hern?ndez A, Di Nardo L, Rocco T, Del Regno L, Badenas C, Carrera C, Malvehy J, Requena C, Ba?uls J, Stratigos AJ, Peris K, Menin C, Calista D, Nagore E, Puig S, Landi MT, Fargnoli MC. High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium. J Eur Acad Dermatol Venereol. 2023 Dec; 37(12):2498-2508.
-
Agarwal A, Philips R, Chitguppi C, Gargano S, Sahin Z, Curry J, Luginbuhl A, Cognetti D, Toskala E, Rabinowitz MR, Rosen MR, Nyquist GG. Effect of p16 Status on Survival Outcomes in Sinonasal Squamous Cell Carcinoma. Ann Otol Rhinol Laryngol. 2023 Aug; 132(8):917-925.
-
Zarrabi KK, Galloway TJ, Flieder DB, Kumar SS, Judd J, Bauman JR. Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer. Head Neck. 2022 08; 44(8):E25-E30.
-
Carey RM, Brody RM, Shimunov D, Shinn JR, Mady LJ, Rajasekaran K, Cannady SB, Lin A, Lukens JN, Bauml JM, Cohen RB, Basu D, O'Malley BW, Weinstein GS, Newman JG. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS. Laryngoscope. 2021 12; 131(12):E2865-E2873.
-
Chung J, Shevchenko A, Lee JB. Evolution of a melanoma in situ to a sarcomatoid dedifferentiated melanoma. J Cutan Pathol. 2021 Jul; 48(7):943-947.
-
Gargano SM, Sebastiano C, Mardekian J, Solomides CC, HooKim K. Cytological interpretation of p16 immunohistochemistry in head and neck carcinomas: does the choice of fixative matter? J Am Soc Cytopathol. 2021 Mar-Apr; 10(2):216-224.
-
Milman T, Zhang Q, Ang S, Elder D, Lally SE, Shields JA, Hamershock RA, Sioufi K, Shields CL, Eagle RC. Immunohistochemical Profiling of Conjunctival Melanocytic Intraepithelial Lesions, Including SOX10, HMB45, Ki67, and P16. Am J Ophthalmol. 2021 02; 222:148-156.